Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Non-Melanoma Skin Carcinoma 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Voriconazole × Clear all
NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

Completed
40,110 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01480219 2013-03-11

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Pfizer

Completed
467 enrolled 6 charts
Dermatologic

Non-Melanoma Skin Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡